RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 22.20
-0.25 (-1.11%)
Aug 19, 2026, 11:11 AM CST
RBC Bioscience Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 220.6 | 219.71 | 205.25 | 172.47 | 173.89 | 251.18 |
Revenue Growth | 0.41% | 7.05% | 19.00% | -0.82% | -30.77% | -56.33% |
Gross Profit Gross Profit Growth | 101.6 | 101.46 | 98.07 | 72.9 | 73.01 | 117.07 |
Operating Income Operating Income Growth | 26.77 | 35.03 | 35.38 | 14.54 | 7.75 | 48.61 |
Net Income Net Income Growth | 21.06 | 23.54 | 21.57 | 6.43 | 3.78 | 28.73 |
Earnings Per Share EPS Growth | 1.47 | 1.64 | 1.50 | 0.45 | 0.26 | 2.13 |
EPS Growth | -10.28% | 9.33% | 236.70% | 69.01% | -87.61% | -80.17% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 14.31 | 13.83 | 14.67 | 20.01 | 17.32 |
Europe Europe Growth | 146.34 | 140.56 | 112.03 | 105.15 | 148.2 |
Asia Asia Growth | 31.69 | 23.93 | 18.07 | 19.66 | 41.86 |
Africa Africa Growth | 14.51 | 13.99 | 16.56 | 10.27 | 17.89 |
America America Growth | 12.84 | 12.83 | 11.08 | 18.79 | 25.9 |
Other Countries Other Countries Growth | 0.02 | 0.11 | 0.07 | - | - |
Total Total Growth | 219.71 | 205.25 | 172.47 | 173.89 | 251.18 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 43.18 | 36.44 | 79.86 | 65.18 | 75.93 | 97.47 |
Total Debt Total Debt Growth | 355.37 | 391.17 | 454.7 | 471.65 | 481.75 | 510.99 |
Net Cash (Debt) Net Cash Growth | -312.19 | -354.73 | -374.84 | -406.47 | -405.82 | -413.52 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -21.77 | -24.66 | -26.11 | -28.42 | -28.35 | -30.57 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 41.4 | 40.52 | 55.93 | 13.21 | 6.6 | -25.3 |
Capital Expenditures CapEx Growth | 0.54 | -6.44 | -2.13 | -4.99 | -9.96 | -449.72 |
Free Cash Flow Free Cash Flow Growth | 41.95 | 34.08 | 53.8 | 8.21 | -3.36 | -475.02 |
Free Cash Flow Growth | 23.06% | -36.64% | 554.94% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 46.05% | 46.18% | 47.78% | 42.27% | 41.98% | 46.61% |
Operating Margin | 12.13% | 15.94% | 17.24% | 8.43% | 4.46% | 19.35% |
Pretax Margin | 11.99% | 13.56% | 13.14% | 4.56% | 2.83% | 14.31% |
Profit Margin | 9.55% | 10.72% | 10.51% | 3.73% | 2.17% | 11.44% |
FCF Margin | 19.01% | 15.51% | 26.21% | 4.76% | -1.93% | -189.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.500 | 1.500 | 0.560 | 0.400 | 1.018 | 0.827 |
Dividend Per Share Growth | 300.00% | 167.86% | 40.00% | -60.71% | 23.19% | -82.05% |
Dividend Yield | 6.82% | 9.40% | 3.46% | 3.07% | 8.53% | 3.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.18 | 10.22 | 11.49 | 32.69 | 54.44 | 15.99 |
P/FCF Ratio | 6.60 | 7.06 | 4.61 | 25.59 | - | - |
PS Ratio | 1.26 | 1.10 | 1.21 | 1.22 | 1.18 | 1.83 |